Inogen Inc (INGN) 40.92 $INGN The Likely Winners in a

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Inogen Inc (INGN) 40.92 $INGN

The Likely Winners in a Medical Device Tax Repeal? Prepare to Be Surprised
Cheryl Swanson, The Motley Fool - Motley Fool - Fri Oct 16, 10:59AM CDT
Medtronic's Twin Cities marathon (Source: Flickr, Creative Commons). If you listen to its critics, the controversial 2.3% Obamacare medical device tax has been a kick in the pants to the entire U.S. medical device industry. In its most recent...
RTIX: 4.83 (-0.08), DXCM: 76.91 (-2.70), MDT: 73.47 (+0.05), INGN: 40.92 (-1.63)

Inogen (INGN) Crumbles: Stock Falls by 5%
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 7:57AM CDT
Inogen, Inc. (INGN) saw a big move last session, as the company's shares fell by 5% on the day
MASI: 38.83 (-1.87), INGN: 40.92 (-1.63)

Top Stocks AMN Healthcare, Inogen Trip Sell Signals
at Investor's Business Daily - Mon Sep 28, 4:30PM CDT
Leading medical stocks AMN Healthcare Services (AHS) and Inogen (INGN) have enjoyed big price gains this year, but they pierced their 50-day moving averages in heavy volume Monday. Time to sell? With the market in a correction, investors should look...
INGN: 40.92 (-1.63), AHS: 25.13 (-6.99)

Top Stocks ICU Medical, Fidelity Southern Hold Tight
at Investor's Business Daily - Wed Sep 23, 3:18PM CDT
Many stocks in the Spotlight screen have shaped new bases or are on the verge of doing so despite the choppy market. A handful of those -- Abiomed (ABMD), Allegiant Travel (ALGT), MaxLinear (MXL), Palo Alto Networks (PANW) and Skechers (SKX) -- have...
ICUI: 105.91 (-2.01), ABMD: 87.69 (-5.85), LION: 20.50 (+0.44), SKX: 45.80 (+0.09), INGN: 40.92 (-1.63), MXL: 13.67 (+0.36), PANW: 163.76 (+3.95), ALGT: 205.38 (-10.59)

Apple Gets Bullish Call; Nike, Amgen PTs Raised
at Investor's Business Daily - Tue Sep 22, 3:28PM CDT
Apple (AAPL) shares fell Tuesday even after the iPhone maker was given a bullish analyst rating and price target, while Nike's (NKE) and Amgen's (AMGN) price targets were hiked. Goldman Sachs assumed coverage on Apple with a buy rating and gave it a...
CI: 128.99 (-7.62), VA: 35.29 (+1.08), NKE: 131.37 (-1.10), EXPE: 127.37 (-1.77), INGN: 40.92 (-1.63), RHT: 77.70 (+0.89), DD: 58.93 (+1.65), COST: 157.18 (+1.97), AMGN: 151.60 (+1.51), CAT: 72.01 (+2.34), AAPL: 115.00 (+1.24)

3 Top Performing Healthcare Stocks To Hold Forever; 1 Getting Ready To Break-Out For The Long-Term
ACCESSWIRE - Tue Sep 22, 9:27AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / September 22, 2015 / The Wealthy Biotech Trader (or "WBT", an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, would like to alert traders about several trade ideas within the very healthy medical device sector.
LMAT: 12.67 (-0.03), SMED: 9.38 (-0.45), INGN: 40.92 (-1.63), IHI: 115.61 (-0.95)

Should You Take Profits In These 4 Leading Stocks?
at Investor's Business Daily - Wed Sep 16, 4:50PM CDT
Four leading stocks have shown tremendous strength in the face of an uncertain market, rising well beyond their buy points. Is it time to take profits? Abiomed (ABMD), Inogen (INGN) and CenterState Banks (CSFL) have given their shareholders a profit...
ABMD: 87.69 (-5.85), INGN: 40.92 (-1.63), CSFL: 14.80 (+0.30), JBLU: 24.67 (+0.41)

Meet The 5 Top-Rated Medical Device Stocks
at Investor's Business Daily - Fri Sep 11, 3:43PM CDT
The recent selloff in drug stocks has dragged down what was once a reliably top-performing sector. Biotech, in particular, seemed permanently lodged in the top 10 of IBD's Industry Group Rankings. But even as biotechs have fallen from the heights, a...
ABMD: 87.69 (-5.85), LMAT: 12.67 (-0.03), INGN: 40.92 (-1.63), VASC: 33.19 (-0.01), CYBX: 69.95 (+0.86)

Inogen Is A Breath Of Fresh Air For Oxygen Patients
at Investor's Business Daily - Tue Sep 08, 5:28PM CDT
The recent sell-off left a lot of newly public companies gasping for air, but shares of portable oxygen concentrator maker Inogen (INGN) are floating even higher. Shares of the Goleta, Calif.-based company have more than tripled since it went public...
ABMD: 87.69 (-5.85), CBM: 40.30 (-0.13), EW: 147.44 (-1.47), INGN: 40.92 (-1.63)

2 Top IPO Stocks Recover Gains After Nasty Sell-Off
at Investor's Business Daily - Mon Aug 24, 3:26PM CDT
Many new issues suffered big declines early Monday along with the overall market . While most IPOs sharply trimmed their losses along with the key market indexes, two stocks showed even healthier recoveries by rising back above their recent buy...
EVHC: 24.20 (-12.29), INGN: 40.92 (-1.63)

Can The Uptrend Continue for Inogen (INGN)?
Zacks Equity Research - Zacks Investment Research - Wed Aug 19, 6:39AM CDT
Can The Uptrend Continue for Inogen (INGN)?
INGN: 40.92 (-1.63)

Mobile Oxygen Machines Breathe Life Into Inogen Stock
at Investor's Business Daily - Mon Aug 17, 4:44PM CDT
Inogen (INGN), a leader in the medical products industry, shows little sign of slowing down. The maker of portable oxygen concentrators is out of buying range after it jumped past a 45.85 buy point of a flat base Aug. 12 on a strong earnings report....
INGN: 40.92 (-1.63)

Four Stocks Hitting Highs On Huge Earnings Growth
at Investor's Business Daily - Fri Aug 14, 4:19PM CDT
Big recent earnings beats have sent a handful of Spotlight names rocketing to new highs. All four showed at least 50% growth in the most recent quarter and three posted an acceleration from growth seen in the prior quarter. Big and accelerating...
DHI: 31.13 (-0.20), INGN: 40.92 (-1.63), STMP: 74.71 (+0.60), AHS: 25.13 (-6.99)

Inogen at 52-Week High on Solid Q2, POC Key Catalyst
Zacks Equity Research - Zacks Investment Research - Thu Aug 13, 11:40AM CDT
Inogen Inc (INGN) attained a new 52-week high of $50.98 on Aug 12, eventually closing a tad bit lower at $48.89.
ABMD: 87.69 (-5.85), MASI: 38.83 (-1.87), INGN: 40.92 (-1.63), THOR: 63.50 (+0.05)

Nasdaq, S&P 500 Close Higher After Impressive Rebound
at Investor's Business Daily - Wed Aug 12, 3:25PM CDT
After an impressive rebound, the broad indexes closed slightly higher Wednesday. The Nasdaq composite climbed 0.2% after being down as much as 1.8%. The composite mirrored a rebound in Apple (AAPL) shares, which closed up 1.5%. The S&P 500 advanced...
INGN: 40.92 (-1.63), TM: 125.37 (+1.67), JD: 26.65 (+0.64), AAPL: 115.00 (+1.24), BABA: 71.11 (+1.63)

Inogen Tops Q2 Earnings & Revenues, '15 Guidance Raised
Zacks Equity Research - Zacks Investment Research - Wed Aug 12, 9:20AM CDT
Inogen, Inc. (INGN) reported second-quarter 2015 adjusted earnings of 17 cents per share, which beat the Zacks Consensus Estimate by a couple of cents and surged 54.5% on a year-over-year basis
RTIX: 4.83 (-0.08), MASI: 38.83 (-1.87), INGN: 40.92 (-1.63), MZOR: 12.00 (+0.06)

Inogen tops Street 2Q forecasts
Automated Insights - Tue Aug 11, 3:37PM CDT
GOLETA, Calif. (AP) _ Inogen Inc. (INGN) on Tuesday reported second-quarter net income of $3.5 million.
INGN: 40.92 (-1.63)

Inogen Announces Second Quarter 2015 Financial Results
GlobeNewswire - Tue Aug 11, 3:05PM CDT
- Record Q2 2015 Total Revenue, Adjusted EBITDA and Net Income -
INGN: 40.92 (-1.63)

R. Scott Greer Joins Inogen Board of Directors
GlobeNewswire - Thu Aug 06, 7:45AM CDT
Inogen, Inc. (NASDAQ:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that R. Scott Greer has been appointed as an independent director to its Board of Directors, effective August 3, 2015. In addition, Mr. Greer was appointed to the Board's Audit Committee. He will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held on October 14, 2015. Mr. Greer fills the vacancy created by the resignation of Timothy Petersen. Mr. Petersen had served as a member of Inogen's Board since 2010.
VSAR: 10.31 (+0.20), STEM: 0.40 (unch), INGN: 40.92 (-1.63), ILMN: 140.24 (+0.07), ASPX: 100.96 (unch), NKTR: 11.21 (+0.10), SIEN: 5.57 (+0.26)

3 IPO Leaders Make A Bullish Case For More Upside
at Investor's Business Daily - Wed Aug 05, 4:30PM CDT
The IPO Leaders screen has yielded some big breakouts lately from the likes of two midcaps, Envision Healthcare (EVHC) and Intrexon (XON). Meanwhile, names like Diplomat Pharmacy (DPLO), Ambarella (AMBA) and Globant (GLOB) continue to show solid...
AMBA: 52.36 (-1.26), GLOB: 33.24 (+0.25), EVHC: 24.20 (-12.29), DPLO: 24.25 (-2.24), XON: 30.71 (-1.13), INGN: 40.92 (-1.63), ESNT: 25.33 (+0.18), MBLY: 47.65 (+0.43)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading